← Back to Screener
60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)
Price$1.42
Value ScoreA
Growth ScoreC
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-74.43%
Price vs S&P 500 (4W)-7.78%
VGM Score48.00
Market Capitalization$3.78M
All Metrics
Book Value / Share (Quarterly)$1.83
P/TBV (Annual)0.66x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)40.21%
Cash Flow / Share (Quarterly)$-3.13
Price vs S&P 500 (YTD)-38.21%
Gross Margin (TTM)39.60%
Net Profit Margin (TTM)-576.30%
EPS (TTM)$-9.79
10-Day Avg Trading Volume0.06M
EPS Excl Extra (TTM)$-9.79
Revenue Growth (5Y)-8.37%
EPS (Annual)$-10.99
ROI (Annual)-203.69%
Gross Margin (Annual)44.52%
Net Profit Margin (5Y Avg)-890.06%
Cash / Share (Quarterly)$1.27
Revenue Growth QoQ (YoY)-36.75%
ROA (Last FY)-137.25%
Revenue Growth TTM (YoY)66.12%
EBITD / Share (TTM)$-7.74
Operating Margin (TTM)-604.05%
Cash Flow / Share (Annual)$-6.08
P/B Ratio0.78x
P/B Ratio (Quarterly)0.96x
Net Income / Employee (Annual)$-2,455,100
EV / Revenue (TTM)0.45x
Net Interest Coverage (TTM)-0.40x
ROA (TTM)-131.78%
EPS Incl Extra (Annual)$-10.99
Current Ratio (Annual)2.66x
Quick Ratio (Quarterly)1.96x
3-Month Avg Trading Volume0.90M
52-Week Price Return-88.01%
Revenue / Employee (TTM)$438,300
Tangible BV / Share (Quarterly)$1.74
P/S Ratio (Annual)2.68x
Asset Turnover (Annual)0.26x
52-Week High$12.96
Operating Margin (5Y Avg)-966.28%
EPS Excl Extra (Annual)$-10.99
CapEx CAGR (5Y)25.17%
26-Week Price Return-66.51%
Quick Ratio (Annual)1.77x
13-Week Price Return-31.07%
Total Debt / Equity (Annual)0.04x
Current Ratio (Quarterly)3.34x
Enterprise Value$590,400
Revenue / Share Growth (5Y)39.94%
Asset Turnover (TTM)0.23x
Revenue / Employee (Annual)$469,700
Inventory Turnover (Annual)1.42x
Pretax Margin (Annual)-522.91%
Cash / Share (Annual)$2.37
3-Month Return Std Dev175.14%
Gross Margin (5Y Avg)20.59%
Net Income / Employee (TTM)$-2,525,900
ROE (Last FY)-212.67%
Net Interest Coverage (Annual)-35.03x
EPS Basic Excl Extra (Annual)$-10.99
Receivables Turnover (TTM)3.19x
Total Debt / Equity (Quarterly)0.03x
EPS Incl Extra (TTM)$-9.79
Receivables Turnover (Annual)2.83x
ROI (TTM)-192.29%
P/S Ratio (TTM)2.87x
Pretax Margin (5Y Avg)-893.97%
Revenue / Share (Annual)$2.10
Tangible BV / Share (Annual)$2.78
Price vs S&P 500 (52W)-112.37%
Year-to-Date Return-30.05%
5-Day Price Return-2.74%
EPS Normalized (Annual)$-10.99
ROA (5Y Avg)-221.05%
Net Profit Margin (Annual)-522.69%
Month-to-Date Return-4.70%
EBITD / Share (Annual)$-11.51
Operating Margin (Annual)-550.60%
LT Debt / Equity (Annual)0.04x
LT Debt / Equity (Quarterly)0.03x
EPS Basic Excl Extra (TTM)$-9.79
P/TBV (Quarterly)1.01x
P/B Ratio (Annual)0.62x
Inventory Turnover (TTM)0.94x
Pretax Margin (TTM)-576.56%
Book Value / Share (Annual)$2.98
Price vs S&P 500 (13W)-39.32%
Beta2.54x
Revenue / Share (TTM)$0.76
ROE (TTM)-200.06%
52-Week Low$1.29
vGradeA
gGradeC
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-1.28est. -0.78
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.13
4.13
4.13
4.00
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SXTP60 Degrees Pharmaceuticals, Inc. Common Stock | A | C | D | $1.42 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
60 Degrees Pharmaceuticals develops specialty pharmaceutical therapies for infectious diseases, including COVID-19, fungal, tick-borne, and viral infections. The company uses biological science and applied research to advance its pipeline toward commercialization.